References
- Bogoch II, Andrews JR, Hohmann EL, Kotton CN, Marty FM. Pandemic H1N1 influenza infection in adult transplant recipients. Transplantation 91(12), e80–e81 (2011).
- Felldin M, Studahl M, Svennerholm B, Friman V. The antibody response to pandemic H1N1 2009 influenza vaccine in adult organ transplant patients. Transpl. Int. 25(2), 166–171 (2012).
- Hansen A, Grund S, Hetzel G et al. Noncontrolled trial of monovalent AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A (H1N1) in long-term dialysis patients and transplant recipients. Am. J. Kidney Dis. 59(3), 471–473 (2012).
- Baluch A, Humar A, Egli A et al. Long-term immune responses to pandemic influenza A/H1N1 infection in solid organ transplant recipients. PLoS One 6(12), e28627 (2011).
- Cordero E, Perez-Ordonez A, Aydillo TA et al. Therapy with m-TOR inhibitors decreases the response to the pandemic influenza A H1N1 vaccine in solid organ transplant recipients. Am. J. Transplant 11(10), 2205–2213 (2011).
- Manuel O, Pascual M, Hoschler K et al. Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients. Clin. Infect. Dis. 52(2), 248–256 (2011).
- Chon WJ, Kadambi PV, Harland RC et al. Changing attitudes toward influenza vaccination in US kidney transplant programs over the past decade. Clin. J. Am. Soc. Nephrol. 5(9), 1637–1641 (2010).
- Kumar D, Blumberg EA, Danziger-Isakov L et al. Influenza vaccination in the organ transplant recipient: review and summary recommendations. Am. J. Transplant 11(10), 2020–2030 (2011).
- Katerinis I, Hadaya K, Duquesnoy R et al. De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients. Am. J. Transplant 11(8), 1727–1733 (2011).
- Danzinger-Isakov L, Kumar D. Guidelines for vaccination of solid organ transplant candidates and recipients. Am. J. Transplant 9(Suppl. 4), S258–S262 (2009).
- Lagler H, Wenisch JM, Tobudic S et al. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination. Vaccine 29(40), 6888–6893 (2011).
- Meyer S, Adam M, Schweiger B et al. Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients. Transplantation 91(9), 1031–1035 (2011).
- Crespo M, Collado S, Mir M et al. Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patients. Clin. J. Am. Soc. Nephrol. 6(9), 2208–2214 (2011).
- Brakemeier S, Schweiger B, Lachmann N et al. Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix®) in renal transplant recipients. Nephrol. Dial. Transplant. 27(1), 423–428 (2012).
- Broeders NE, Hombrouck A, Lemy A et al. Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study. Clin. J. Am. Soc. Nephrol. 6(11), 2573–2578 (2011).
- Miraglia JL, Abdala E, Hoff PM et al. Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients. PLoS One 6(11), e27214 (2011).
- Beaudreuil S, Krivine A, Hebibi H et al. Efficacy and safety of the H1N1 monovalent vaccine in renal-transplant recipients and dialysis patients. Hum. Vaccin. 7(8), 868–873 (2011).